Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating Effect Of GlcNAc On Tear Production In Individuals With NGLY1-CDDG

NCT05402345 is registered in ClinicalTrials.gov with Eva Morava-Kozicz as lead sponsor.

NCT NCT05402345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating Effect Of GlcNAc On Tear Production In Individuals With NGLY1-CDDG
Lead sponsor
Eva Morava-Kozicz
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 24, 2025
Completion date
December 31, 2027
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ngly1 deficiency